Rexulti in Combination With Sertraline for PTSD: Upcoming FDA Advisory Committee Discussion
Summary by psychiatrictimes.com
2 Articles
2 Articles
FDA staff question efficacy of Otsuka's Rexulti combo for PTSD ahead of adcomm
The FDA is questioning whether Otsuka's Rexulti in combination with the antidepressant Zoloft has enough efficacy data to back an approval as a new treatment for post-traumatic stress disorder. The agency's Psychopharmacologic Drugs Advisory Committee ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium